Cargando…
Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
BACKGROUND: Hematologic malignancies arising in the setting of established germ cell tumors have been previously described and have a dismal prognosis. Identification of targetable mutations and pathway dysregulation through massively parallel sequencing and functional assays provides new approaches...
Autores principales: | Leonard, Jessica T., Raess, Philipp W., Dunlap, Jennifer, Hayes-Lattin, Brandon, Tyner, Jeffrey W., Traer, Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815159/ https://www.ncbi.nlm.nih.gov/pubmed/27036514 http://dx.doi.org/10.1186/s13045-016-0258-1 |
Ejemplares similares
-
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022) -
Acute megakaryoblastic leukemia arising in a mediastinal mixed germ cell tumor
por: Alrohaibani, Alaaeddin, et al.
Publicado: (2021) -
Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia
por: Oyogoa, Emmanuella, et al.
Publicado: (2023) -
The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML
por: Dunlap, Jennifer B., et al.
Publicado: (2019) -
Acute myeloid leukemia following a primary mediastinal germ cell tumor
por: Hong, Huimin, et al.
Publicado: (2020)